Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew

This publication has 40 references indexed in Scilit:

• Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists
  Brain Research, 2008
• A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research
  Brain Research, 2007
• Brain Fos expression during 48 h after cisplatin treatment: Neural pathways for acute and delayed visceral sickness
  Autonomic Neuroscience, 2007
• New Approaches to Chemotherapy-Induced Nausea and Vomiting
  The Cancer Journal, 2006
• Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain
  Neuropsychobiology, 2006
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
  European Journal Of Cancer, 2003
• Serotonin 5-HT 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
• An efficient new cannabinoid antiemetic in pediatric oncology
  Life Sciences, 1995
• Use of C-Fos Functional Mapping to Identify the Central Baroreceptor Reflex Pathway: Advantages and Limitations
  Clinical and Experimental Hypertension, 1995
• Immunohistochemical and biochemical analysis of serotonin and substance P colocalization in the nucleus tractus solitarii and associated afferent ganglia of the rat
  Synapse, 1988